Insider Trading History of Dougherty Michael R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Dougherty Michael R since 2008. This trader's CIK number is 1033516. At the time of last reporting, Dougherty Michael R was the Officer of Idera Pharmaceuticals, Inc.. (stock ticker symbol IDRA). Also see all insider trading activities at Idera Pharmaceuticals, Inc..

Note that in the past DOUGHERTY MICHAEL R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Idera Pharmaceuticals, Inc. (IDRA) by Dougherty Michael R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 IDRA 85,000 $101,150 0 $0 0 $0

Yearly summary of insider trading at Adolor Corp (ADLR) by Dougherty Michael R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ADLR 0 $0 0 $0 698,750 $1,841,206
2010 ADLR 30,000 $35,400 0 $0 0 $0
2009 ADLR 76,100 $144,645 0 $0 0 $0
2008 ADLR 25,000 $39,750 0 $0 21,500 $0

Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (CEMP) by Dougherty Michael R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 CEMP 2,000 $36,896 0 $0 0 $0

Yearly summary of insider trading at Celator Pharmaceuticals Inc (CPXX) by Dougherty Michael R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CPXX 20,000 $42,939 0 $0 0 $0

Yearly summary of insider trading at Viropharma Inc (VPHM) by Dougherty Michael R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 VPHM 0 $0 0 $0 10,000 $34,200
2012 VPHM 2,500 $62,675 0 $0 0 $0
2008 VPHM 0 $0 45,000 $574,245 45,000 $144,450

Yearly summary of insider trading at Trevena Inc (TRVN) by Dougherty Michael R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 TRVN 7,000 $28,000 0 $0 0 $0


Insider trading activities at 6 companies by Dougherty Michael R:

1. Idera Pharmaceuticals, Inc. (IDRA)

2. Adolor Corp (ADLR)

3. Melinta Therapeutics, Inc. /new/ (CEMP)

4. Celator Pharmaceuticals Inc (CPXX)

5. Viropharma Inc (VPHM)

6. Trevena Inc (TRVN)

Table 1. Insider trading of Idera Pharmaceuticals, Inc. (IDRA) by Dougherty Michael R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-06-01 IDRA Buy 85,000 1.19 101,150

Table 2. Insider trading of Adolor Corp (ADLR) by Dougherty Michael R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-12-07 ADLR Option Ex 698,750 2.63 1,841,206
2010-12-23 ADLR Buy 30,000 1.18 35,400
2009-01-22 ADLR Buy 25,000 1.90 47,500
2009-01-16 ADLR Buy 26,100 1.95 50,895
2009-01-09 ADLR Buy 25,000 1.85 46,250
2008-11-20 ADLR Buy 25,000 1.59 39,750
2008-05-20 ADLR Option Ex 21,500 .00 0

Table 3. Insider trading of Melinta Therapeutics, Inc. /new/ (CEMP) by Dougherty Michael R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-10-26 CEMP Buy 2,000 18.45 36,896

Table 4. Insider trading of Celator Pharmaceuticals Inc (CPXX) by Dougherty Michael R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-11-18 CPXX Buy 20,000 2.15 42,939

Table 5. Insider trading of Viropharma Inc (VPHM) by Dougherty Michael R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-18 VPHM Option Ex 10,000 3.42 34,200
2012-12-03 VPHM Buy 2,500 25.07 62,675
2008-11-03 VPHM Option Ex 45,000 3.21 144,450
2008-11-03 VPHM Sale 45,000 12.76 574,245

Table 6. Insider trading of Trevena Inc (TRVN) by Dougherty Michael R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-12-10 TRVN Buy 7,000 4.00 28,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dougherty Michael R (Officer of Idera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.